Pre-Filled Syringes West Coast 2017
05 June 2017 - 06 June 2017
SMi Group are thrilled to announce the return of Pre-Filled Syringes West Coast 2017 which arrives to California on June 5th & 6th.
Following on from sell-out shows in Europe and Boston, Pre-Filled Syringes West Coast will once again gather a global audience of medical device experts and PFS industry leaders to discuss new advancements and showcase cutting edge advances, keeping you at the forefront of a booming industry.
The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Innovation and excellence is requested at every level making Pre-Filled Syringes West Coast the perfect platform to strengthen knowledge in key principles such as human factor engineering, manufacturing and complex biologics, whilst honing in on emerging trends for parenteral devices, including auto injectors, pens, pumps and smart devices.
“It is critical to develop working relationships and collaborations, as an industry, to bring knowledge to the suppliers and drug developers worldwide, so that we can address these challenges. Thank you to everyone who contributes to this goal and looking forward to your participation at the conference." - Speaker and Conference Chair: Mike Stelmah, Senior Manager, Combination Products Regulatory Affairs, Regeneron
The notable speaker line-up will include:
• John Smith, Director, Global Regulatory Affairs, Allergan
• Anand Subramony, Vice President Drug Delivery & Device Development, MedImmune
• Benir Ruano, VP, Global Manufacturing and Technical Operations, Xeris Pharmaceuticals
• Ron Forster, Executive Director, Amgen
• Sara McNew, Director, Human Factors and Industrial Design, Eli Lilly
• Alasdair Young, Device Engineer, Genentech
• Lori de los Reyes, Global Regulatory Affairs, Amgen
• Ariel Waitz, Senior Engineer, Genentech
• Aaron Chesterman, Principal Engineer, Device Development, Genentech
• Tina Rees, Associate Director – Human Factors, Ferring
• Mayumi Bowen, Senior Engineer, Genentech
• Monica de Bardi, Postdoctoral Researcher, Roche
We will also be welcoming expertise from the likes of Nemera, Nipro PharmaPackaging, Terumo, Worrell, Zeon + more!
Reasons to sign up:
• Explore and harness the global regulatory ecosystem; global compliance requirements for product safety and risk analysis
• Assess data bridging and risk based control strategies for combination products
• Map the importance of Human factors and patient centricity in device design
• Highlight the emerging trends of connected health and the future of patient centric drug delivery
• Cutting edge industry insight on silicone free devices, virtual reality, and laser cutting in the design and manufacture of prefilled devices
For more information or to register, visit http://www.prefilled-syringes-westcoast.com/drugdiscoverytoday
To get in touch, contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
Hyatt Regency Mission Bay, San Diego, CA, USA
https://www.smi-online.co.uk/pharmaceuticals/northamerica/Pre-Filled-Syringes-West-Coast?utm_medium=www.prefilled-syringes-westcoast.com&utm_source=P-209&utm_campaign=drugdiscoverytoday
Pharmaceutical Microbiology USA
08 June 2017 - 09 June 2017
Drawing on from the huge success of SMi’s Pharmaceutical Microbiology UK events, SMi is delighted to announce the launch of Pharmaceutical Microbiology USA. The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology USA 2017 will address the current challenges and developing trends of the pharmaceutical microbiology field.
Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more…
Speaker Line-Up Includes: Janssen, Amgen, Takeda, Merck, Bimeda, Excellent Pharma Consulting, Roche Molecular Systems, Microrite and many more…
Early birds available!
For details or to register, visit the website at www.pharma-microbiology-usa.com/drugdiscovery or contact the team at +44(0) 207827 6000, email zgale@smi-online.co.uk
Hyatt Regency Mission Bay, San Diego, CA, USA
https://www.smi-online.co.uk/pharmaceuticals/northamerica/Microbiology-USA?utm_medium=www.pharma-microbiology-usa.com&utm_source=P-217&utm_campaign=drugdiscovery
4th Annual Immunogenicity
12 June 2017 - 13 June 2017
SMi is thrilled to present the return of its 4th annual immunogenicity conference, taking place in London. This conference will provide guests with a thorough understanding of the continued research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Delegates will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/Immunogenicity?utm_medium=www.immuno.co.uk&utm_source=P-211&utm_campaign=drugdiscovery#tab_venue
Biobanking 2017
14 June 2017 - 15 June 2017
SMi's 7th annual conference on Biobanking will bring together Europe’s leading biorepositories, regulatory representatives and scientific pioneers to strengthen knowledge in biosample management as well as explore future advances in areas such as mobile bio-banking and cloud based sample management.
Understanding the ethical and regulatory framework as well as the impact of the General Data Protection Regulation (GDPR) on collaborative science in Europe will be a major focus. Plus, don’t miss keynote addresses from a selection of European biobanks currently adding value to clinical research through successful biobanking strategies including the European Sperm Bank, UK Biobank, UCL Baby Biobank, Auria Biobank and more.
Exclusive updates from the European Commission and NIBSC-MHRA, will be just some of the event highlights for 2017. Join us this June for innovative discussions through a series of interactive presentations, panel discussions and roundtables, and address relevant and critical issues on how to improve your biobanking practice.
Holiday Inn Kensington Forum, London, UK
http://www.bio-banking-event.com/ddt
In Vitro Diagnostics 2017
14 June 2017 - 15 June 2017
The third in its series, SMi is delighted to announce the return of In Vitro Diagnostics taking place in London on the 14th & 15th June 2017. Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.
Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017 event will prepare attendees for the challenging times ahead and how to comply with regulatory requirements to ensure direct access to market ensuring the continued growing demand for use and innovation of IVDs over the next decade and beyond. Topics of discussion include: Latest updates on the IVD regulation, the changing role of notified bodies as well as the increase in requirements for clinical evidence.
Speakers include: FDA, MHRA, LNE/GMED North America, LRQA, TÜV SÜD, Ortho Clinical Diagnostics, DEKRA and many more…
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/in-vitro-diagnostics?utm_medium=www.in-vitro-diagnostics.co.uk&utm_source=P-216&utm_campaign=drugdiscovery
Innovation Pipeline & Portfolio Amplification
20 June 2017 - 20 June 2017
Innovation moves pretty fast—if you don’t stop and strategize, you might miss it.
Breakthrough products and disruptive technology are hitting the market at ever-accelerating rates. To stay relevant in this competitive marketplace, innovators need a streamlined approach to pipeline and portfolio management—one that optimizes strategic direction, decision making, project prioritization, and resource allocation. Innovators need a holistic approach to portfolio advancement
This marcus evans conference will amplify the performance of diverse innovation pipeline & portfolios. It will establish best practices to achieve the highest possible ROI from a value-based, growth-driving innovation pipeline. The delegation will hone the abilities to direct innovation toward strategic initiatives, improve decision making, and enhance top-priority resource allocation across diverse portfolios.
tbc Philadelphia, PA, USA
http://www.marcusevans-conferences-northamerican.com/marcusevans-conferences-event-details.asp?eventID=23760§orID=#.WUlKHJDyvct